Dual effect of CCR5 Δ32 gene deletion in HIV-1-infected patients
- 1 June 1997
- journal article
- Published by Elsevier in The Lancet
- Vol. 349 (9069), 1884
- https://doi.org/10.1016/s0140-6736(05)63874-3
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progressionNature Medicine, 1997
- Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individualsAIDS, 1997
- Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural GeneScience, 1996
- Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor geneNature, 1996
- Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 InfectionCell, 1996